Literature DB >> 16680143

Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes.

Shalin H Naik1, Donald Metcalf, Annemarie van Nieuwenhuijze, Ian Wicks, Li Wu, Meredith O'Keeffe, Ken Shortman.   

Abstract

Immediate precursors of the many subtypes of dendritic cells (DCs) remain obscure. Here we purified a splenic precursor population that produced all splenic CD8+ and CD8- conventional DCs (cDCs) but not plasmacytoid DCs or other lineages. This 'pre-cDC' population included cells 'precommitted' to form either CD8+ or CD8- cDCs. The pre-cDCs, which comprised 0.05% of splenocytes, expressed a CD11c(int) CD45RA(lo) CD43(int) SIRP-alpha(int) CD4- CD8- major histocompatibility complex class II-negative surface phenotype. The pre-cDCs were not monocytes. Monocytes generated few cDCs in steady-state recipient mice. However, when transferred into mice with an inflammatory milieu dependent on granulocyte-macrophage colony-stimulating factor, monocytes produced a distinct type of splenic DC. Thus, the inflammatory status of the host influences the developmental origin and type of DC present in lymphoid tissues.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16680143     DOI: 10.1038/ni1340

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  226 in total

1.  Flt3 permits survival during infection by rendering dendritic cells competent to activate NK cells.

Authors:  Céline Eidenschenk; Karine Crozat; Philippe Krebs; Ramon Arens; Daniel Popkin; Carrie N Arnold; Amanda L Blasius; Chris A Benedict; Eva Marie Y Moresco; Yu Xia; Bruce Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

2.  The earliest intrathymic precursors of CD8α(+) thymic dendritic cells correspond to myeloid-type double-negative 1c cells.

Authors:  Hervé Luche; Laurence Ardouin; Pearline Teo; Peter See; Sandrine Henri; Miriam Merad; Florent Ginhoux; Bernard Malissen
Journal:  Eur J Immunol       Date:  2011-07-04       Impact factor: 5.532

Review 3.  Transcriptional programming of the dendritic cell network.

Authors:  Gabrielle T Belz; Stephen L Nutt
Journal:  Nat Rev Immunol       Date:  2012-01-25       Impact factor: 53.106

Review 4.  Functional regulation of monocyte-derived dendritic cells by microRNAs.

Authors:  Yifan Zhan; Li Wu
Journal:  Protein Cell       Date:  2012-07-10       Impact factor: 14.870

5.  GM-CSF-induced, bone-marrow-derived dendritic cells can expand natural Tregs and induce adaptive Tregs by different mechanisms.

Authors:  Palash Bhattacharya; Anupama Gopisetty; Balaji B Ganesh; Jian Rong Sheng; Bellur S Prabhakar
Journal:  J Leukoc Biol       Date:  2010-11-02       Impact factor: 4.962

6.  Ly6C(low) monocytes differentiate into dendritic cells and cross-tolerize T cells through PDL-1.

Authors:  YuFeng Peng; Yvette Latchman; Keith B Elkon
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

Review 7.  Recent progress in understanding the phenotype and function of intestinal dendritic cells and macrophages.

Authors:  B Kelsall
Journal:  Mucosal Immunol       Date:  2008-09-17       Impact factor: 7.313

Review 8.  Dendritic cells and macrophages in the genitourinary tract.

Authors:  N Iijima; J M Thompson; A Iwasaki
Journal:  Mucosal Immunol       Date:  2008-09-10       Impact factor: 7.313

9.  Deficiency of lymph node-resident dendritic cells (DCs) and dysregulation of DC chemoattractants in a malnourished mouse model of Leishmania donovani infection.

Authors:  Marwa K Ibrahim; Jeffrey L Barnes; E Yaneth Osorio; Gregory M Anstead; Fabio Jimenez; John J Osterholzer; Bruno L Travi; Seema S Ahuja; A Clinton White; Peter C Melby
Journal:  Infect Immun       Date:  2014-05-12       Impact factor: 3.441

10.  METEORIN-LIKE is a cytokine associated with barrier tissues and alternatively activated macrophages.

Authors:  Irina Ushach; Amanda M Burkhardt; Cynthia Martinez; Peter A Hevezi; Peter Arne Gerber; Bettina Alexandra Buhren; Holger Schrumpf; Ricardo Valle-Rios; Monica I Vazquez; Bernhard Homey; Albert Zlotnik
Journal:  Clin Immunol       Date:  2014-12-05       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.